Latest form 40-F annual reports for Aurinia Pharmaceuticals CIK: 0001600620The 40-F is the annual report that Canadian companies file with the SEC instead of a 10-K. It contains the annual information form, MD&A and financial statements of Aurinia Pharmaceuticals
Language: English